| Product NDC: | 66336-479 | 
| Proprietary Name: | Dexamethasone | 
| Non Proprietary Name: | Dexamethasone | 
| Active Ingredient(s): | 4 mg/1 & nbsp; Dexamethasone | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 66336-479 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA084612 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19780719 | 
| Package NDC: | 66336-479-40 | 
| Package Description: | 40 TABLET in 1 BOTTLE (66336-479-40) | 
| NDC Code | 66336-479-40 | 
| Proprietary Name | Dexamethasone | 
| Package Description | 40 TABLET in 1 BOTTLE (66336-479-40) | 
| Product NDC | 66336-479 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Dexamethasone | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19780719 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | DEXAMETHASONE | 
| Strength Number | 4 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |